RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ITRM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Iterum Therapeutics Plc stock price on Thursday which ended trading at $1.54
(Updated on Mar 28, 2024)

Sell candidate since Mar 28, 2024 PDF

The Iterum Therapeutics Plc stock price fell by -3.14% on the last day (Thursday, 28th Mar 2024) from $1.59 to $1.54. During the last trading day the stock fluctuated 11.33% from a day low at $1.50 to a day high of $1.67. The price has risen in 6 of the last 10 days and is up by 6.21% over the past 2 weeks. Volume has increased on the last day by 81 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 225 thousand shares were bought and sold for approximately $347.20 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.56 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -26.87% during the next 3 months and, with a 90% probability hold a price between $0.770 and $1.14 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ITRM Signals & Forecast

The Iterum Therapeutics Plc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.57. On a fall, the stock will find some support from the long-term average at approximately $1.48. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, March 12, 2024, and so far it has fallen -7.78%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Iterum Therapeutics Plc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Iterum Therapeutics Plc stock

Iterum Therapeutics Plc finds support from accumulated volume at $1.49 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.170 between high and low, or 11.33%. For the last week, the stock has had daily average volatility of 6.56%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ITRM) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Iterum Therapeutics Plc to open at $1.57, and during the day (based on 14 day Average True Range), to move between $1.42 and $1.66, which gives a possible trading interval of +/-$0.118 (+/-7.69%) up or down from last closing price. If Iterum Therapeutics Plc takes out the full calculated possible swing range there will be an estimated 15.38% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.57 (1.95%) than the support at $1.49 (3.25%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Iterum Therapeutics Plc stock A Buy?

Iterum Therapeutics Plc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -1.723 Sell Candidate Downgraded

Predicted Opening Price for Iterum Therapeutics Plc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$1.57 ( 1.94%) $1.54

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ITRM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.74 12.98 %
R2 1.67 8.77 %
R1 1.63 6.16 %
Current price: 1.54
Support S1 1.50 -2.27 %
S2 1.46 -4.88 %
S3 1.40 -9.10 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.65 7.14 %
R2 1.58 2.60 %
R1 1.57 1.95 %
Current price 1.54
Support S1 1.49 -3.25%
S2 1.44 -6.49%
S3 1.27 -17.53%

FAQ

What is the symbol for Iterum Therapeutics Plc Stock and on which exchange is it traded?
The symbol for Iterum Therapeutics Plc is ITRM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Iterum Therapeutics Plc Stock?
Iterum Therapeutics Plc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Iterum Therapeutics Plc Stock?
Iterum Therapeutics Plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Iterum Therapeutics Plc Stock.

What's the current price of Iterum Therapeutics Plc Stock?
As of the end of day on the 2024-03-28, the price of an Iterum Therapeutics Plc (ITRM) share was $1.54.

What is the 52-week high and low for Iterum Therapeutics Plc Stock?
The 52-week high for Iterum Therapeutics Plc Stock is $2.50 and the 52-week low is $0.622.

What is the market capitalization of Iterum Therapeutics Plc Stock?
As of the 2024-03-28, the market capitalization of Iterum Therapeutics Plc is 20.933M.

When is the next earnings date for Iterum Therapeutics Plc?
The upcoming earnings date for Iterum Therapeutics Plc is Mar 28, 2024.
Click to get the best stock tips daily for free!

About Iterum Therapeutics Plc

Iterum Therapeutics Plc Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company ... ITRM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT